- THIS ARTICLE
- Full Text
- Full Text (PDF)
- Supporting Information
-
All Versions of this Article:
genetics.109.107284v1
183/3/821 most recent - Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Shao, Z.
- Articles by Powell-Coffman, J. A.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Shao, Z.
- Articles by Powell-Coffman, J. A.
Originally published as Genetics Published Articles Ahead of Print on September 7, 2009.
Genetics, Vol. 183, 821-829, November 2009, Copyright © 2009
doi:10.1534/genetics.109.107284
Two Distinct Roles for EGL-9 in the Regulation of HIF-1-Mediated Gene Expression in Caenorhabditis elegans
Zhiyong Shao, Yi Zhang and Jo Anne Powell-Coffman1
Department of Genetics, Development, and Cell Biology, Iowa State University, Ames, Iowa 50011-3260
1 Corresponding author: 2108 Molecular Biology Bldg., Iowa State University, Ames, IA 50011-3260.
E-mail: japc{at}iastate.edu
Oxygen is critically important to metazoan life, and the EGL-9/PHD enzymes are key regulators of hypoxia (low oxygen) response. When oxygen levels are high, the EGL-9/PHD proteins hydroxylate hypoxia-inducible factor (HIF) transcription factors. Once hydroxylated, HIF
subunits bind to von Hippel-Lindau (VHL) E3 ligases and are degraded. Prior genetic analyses in Caenorhabditis elegans had shown that EGL-9 also acted through a vhl-1-independent pathway to inhibit HIF-1 transcriptional activity. Here, we characterize this novel EGL-9 function. We employ an array of complementary methods to inhibit EGL-9 hydroxylase activity in vivo. These include hypoxia, hydroxylase inhibitors, mutation of the proline in HIF-1 that is normally modified by EGL-9, and mutation of the EGL-9 catalytic core. Remarkably, we find that each of these treatments or mutations eliminates oxygen-dependent degradation of HIF-1 protein, but none of them abolishes EGL-9-mediated repression of HIF-1 transcriptional activity. Further, analyses of new egl-9 alleles reveal that the evolutionarily conserved EGL-9 MYND zinc finger domain does not have a major role in HIF-1 regulation. We conclude that C. elegans EGL-9 is a bifunctional protein. In addition to its well-established role as the oxygen sensor that regulates HIF-1 protein levels, EGL-9 inhibits HIF-1 transcriptional activity via a pathway that has little or no requirement for hydroxylase activity or for the EGL-9 MYND domain.